Maternal serum endoglin as an early marker of pre-eclampsia in high-risk patients

Abstract

Estimation of serum soluble endoglin at gestational week 13 could be used as a sensitive screening test for women at high risk of developing pre-eclampsia prior to onset of its clinical manifestations, which could potentially improve the outcome of pregnancy.